Medical management of first-trimester abortion

Contraception. 2014 Mar;89(3):148-61. doi: 10.1016/j.contraception.2014.01.016.
No abstract available

MeSH terms

  • Abortifacient Agents* / adverse effects
  • Abortifacient Agents, Nonsteroidal
  • Abortifacient Agents, Steroidal
  • Abortion, Induced / adverse effects
  • Abortion, Induced / methods*
  • Chorionic Gonadotropin / blood
  • Counseling
  • Evidence-Based Medicine
  • Female
  • Gestational Age*
  • Humans
  • Mifepristone / administration & dosage
  • Mifepristone / adverse effects
  • Misoprostol / administration & dosage
  • Misoprostol / adverse effects
  • Pregnancy
  • United States
  • United States Food and Drug Administration

Substances

  • Abortifacient Agents
  • Abortifacient Agents, Nonsteroidal
  • Abortifacient Agents, Steroidal
  • Chorionic Gonadotropin
  • Misoprostol
  • Mifepristone